Stocks making the biggest moves premarket: Delta, Tesla, Moderna and others

Stocks making the biggest moves premarket: Delta, Tesla, Moderna and others


News Update – Pre-Markets

Check out the companies making headlines before the bell:

Delta Air Lines (DAL) – Delta jumped 3.8% in the premarket after the airline raised its current quarter forecast and issued an upbeat 2023 outlook, citing robust travel demand.

Tesla (TSLA) – Goldman Sachs cut its price target for Tesla to $235 per share from $305, citing softer demand. Tesla shares are down about 40% since the end of September, and briefly dipped below $500 billion in market value Tuesday.

Moderna (MRNA) – Moderna rose another 1.6% in premarket trading on top of yesterday’s 19.6% gain. The Tuesday advance followed a successful study of a skin cancer treatment involving an experimental Moderna vaccine in combination with Merck‘s (MRK) cancer drug Keytruda.

Best Buy (BBY) – The electronics retailer’s stock dropped 3% in premarket action after BofA Securities downgraded it to underperform from neutral, citing a challenging environment for achieving earnings growth.

Aspen Group (ASPU) – Aspen Group rallied 14.8% in premarket action after the online education company reported better-than-expected quarterly revenue and improved profit margins.

ABM Industries (ABM) – ABM Industries reported better-than-expected profit and revenue for its latest quarter. But the provider of facility services gave an outlook that fell below consensus estimates. The stock slid 3.9% in premarket trading.

Darden Restaurants (DRI) – The parent of Olive Garden and other restaurant chains was upgraded to outperform from neutral at Wedbush on expectations of market share gains for Darden amid an uncertain consumer environment. Darden rose 1% in the premarket.

Paccar (PCAR) – Paccar gained 1.6% in the premarket after the truck maker’s stock was upgraded to overweight from equal-weight at Morgan Stanley, which also raised its price target to $136 per share from $91. The firm said Paccar is among the industrial stocks poised to benefit from a sector recovery.



Source

Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More
Advisors to the ultra rich say AI isn’t a gamechanger for landing new clients
Business

Advisors to the ultra rich say AI isn’t a gamechanger for landing new clients

D3sign | Moment | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Market data firms have been pitching artificial intelligence as the key to locating elusive ultra-high-net-worth clients. But […]

Read More